Fibroblast Growth Factor-23 and Risk of Cardiovascular Diseases

Clinical Journal of the American Society of Nephrology (CJASN)

10-01-2023 • 4 minutos

Dr. Killian Donovan provides an overview of the conclusions from his study "Fibroblast Growth Factor-23 and Risk of Cardiovascular Diseases," on behalf of his colleagues.